TARDBP and amyotrophic lateral sclerosis: Overall, Sephin1 improves motor neuron survival in multiple preclinical ALS models by reducing TDP-43 cytoplasmic mislocalization and reducing abnormal splicing due to TDP-43 nuclear loss of function suggesting that Sephin1 could be a therapeutic strategy for ALS patients.